Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group.

By R. Womer, D. West, M. Krailo, P. Dickman, B. Pawel, H. Grier, K. Marcus, S. Sailer, J. Healey, J. Dormans and 1 more. Journal of Clinical Oncology, 2012

614 citations recorded by the source corpus.

Subfields: Nutrition and Dietetics

View Paper: https://www.semanticscholar.org/paper/928c7a5657ab660bbba63938ae44be64b481053c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Thomas J. Smith
2. Kari Bohlke
3. G. Lyman
4. K. Carson
5. J. Crawford
6. Scott J. Cross
7. J. Goldberg
8. N. Gaspar

Citations in the corpus

• Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. (2015, methodology): “Literature Review Update and Analysis Chemotherapy intensification through interval compression was evaluated in an RCT of patients age 50 years with newly diagnosed, localized Ewing sarcoma.(57) Chemotherapy consisted of alternating cycles of vincristine, doxorubicin, and cyclophosphamide and of if”
• Ewing Sarcoma: Current Management and Future Approaches Through Collaboration. (2015, background): “There was also no increase in toxicity observed with the compressed schedule.(5) High-dose chemotherapy followed by stem-cell rescue for ES is based on dose-response and dose-intensity relationships.”